Silencing urokinase in the ventral tegmental area in vivo induces changes in cocaine-induced hyperlocomotion

被引:18
作者
Bahi, Amine
Boyer, Frederic
Kafri, Tal
Dreyer, Jean-Luc
机构
[1] Univ Fribourg, Inst Biochem, CH-1700 Fribourg, Switzerland
[2] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC USA
关键词
addiction; in vivo gene transfer; lentivirus; plasticity; small interfering RNA; urokinase-type plasminogen activator;
D O I
10.1111/j.1471-4159.2006.04013.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Serine proteases in the nervous system have functional roles in neural plasticity. Among them, urokinase-type plasminogen activator (uPA) exerts a variety of functions during development, and is involved in learning and memory. Furthermore, psychostimulants strongly induce uPA expression in the mesolimbic dopaminergic pathway. In this study, doxycycline-regulatable lentiviruses expressing either uPA, a dominant-negative form of uPA, or non-regulatable lentiviruses expressing small interfering RNAs (siRNAs) targeted against uPA have been prepared and injected into the ventral tegmental area (VTA) of rat brains. Over-expression of uPA in the VTA induces doxycycline-dependent expression of its receptor, uPAR, but not its inhibitor, plasminogen activator inhibitor-1 (PAI-1). uPAR expression in the VTA is repressed upon silencing of uPA with lentiviruses expressing siRNAs. In addition, over-expression of uPA in the VTA promotes a 15-fold increase in locomotion activity upon cocaine delivery. Animals expressing the dominant-negative form of uPA did not display such hyperlocomotor activity. These cocaine-induced behavioural changes, associated with uPA expression, could be suppressed in the presence of doxycycline or uPA-specific siRNAs expressing lentiviruses. These data strongly support the major role of urokinase in cocaine-mediated plasticity changes.
引用
收藏
页码:1619 / 1631
页数:13
相关论文
共 67 条
[11]   Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? [J].
Deng, G ;
Curriden, SA ;
Wang, SJ ;
Rosenberg, S ;
Loskutoff, DJ .
JOURNAL OF CELL BIOLOGY, 1996, 134 (06) :1563-1571
[12]   UROKINASE-TYPE PLASMINOGEN-ACTIVATOR EXPRESSION BY NEURONS AND OLIGODENDROCYTES DURING PROCESS OUTGROWTH IN DEVELOPING RAT-BRAIN [J].
DENT, MAR ;
SUMI, Y ;
MORRIS, RJ ;
SEELEY, PJ .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1993, 5 (06) :633-647
[13]  
Evans DM, 2000, AM SURGEON, V66, P460
[14]  
Fiorillo C D, 1998, Adv Pharmacol, V42, P1002
[15]  
FLUMELLI H, 1999, EUR J NEUROSCI, V11, P1639
[16]  
Frey U, 1996, J NEUROSCI, V16, P2057
[17]   Spatial regulation and activity modulation of plasmin by high affinity binding to the G domain of the α3 subunit of laminin-5 [J].
Goldfinger, LE ;
Jiang, LH ;
Hopkinson, SB ;
Stack, MS ;
Jones, JCR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (45) :34887-34893
[18]   No association is found between the candidate genes of t-PA/plasminogen system and Japanese methamphetamine-related disorder - A collaborative study by the Japanese genetics initiative for drug abuse [J].
Iwata, N ;
Inada, T ;
Harano, M ;
Komiyama, T ;
Yamada, M ;
Sekine, Y ;
Iyo, M ;
Sora, I ;
Ujike, H ;
Ozaki, N .
CURRENT STATUS OF DRUG DEPENDENCE / ABUSE STUDIES: CELLULAR AND MOLECULAR MECHANISMS OF DRUGS OF ABUSE AND NEUROTOXICITY, 2004, 1025 :34-38
[19]   Neuroscience of addiction [J].
Koob, GF ;
Sanna, PP ;
Bloom, FE .
NEURON, 1998, 21 (03) :467-476
[20]  
Ma Z, 2001, J CELL SCI, V114, P3387